What is LeadsRx?
Founded in 2015, LeadsRx operates as a specialized SaaS platform designed to solve the persistent challenge of cross-channel marketing attribution. The company provides a robust suite of tools that enable organizations to track, monitor, and optimize marketing campaigns across diverse social media and digital channels. By centralizing data from disparate sources, LeadsRx empowers marketing teams to gain granular visibility into the customer journey, ultimately driving higher return on investment. Its market position is defined by its ability to bridge the gap between raw engagement data and actionable business intelligence, serving as a foundational layer for data-driven marketing strategies.
How much funding has LeadsRx raised?
LeadsRx has raised a total of $160K across 2 funding rounds:
Other Financing Round
$10K
Debt
$150K
Other Financing Round (2015): $10K with participation from AJ Brown
Debt (2020): $150K led by PPP
Key Investors in LeadsRx
AJ Brown
An individual investor providing early-stage capital to support the foundational development of marketing attribution technology.
PPP
Public-Private Partnership
What's next for LeadsRx?
With the successful closure of this late-stage funding round, LeadsRx is well-positioned to scale its operations and enhance its technological infrastructure. The strategic focus will likely shift toward deepening its integration capabilities with major advertising ecosystems and expanding its footprint within the enterprise sector. As the demand for transparent, privacy-compliant attribution grows, the company is poised to capitalize on its existing momentum to capture a larger share of the marketing analytics market. Future growth will be predicated on the firm's ability to maintain its technical edge while scaling its customer success and sales organizations to meet the needs of a global client base.
See full LeadsRx company page
